INFLUENCE OF GADOLINIUM CHELATES ON P-31 MAGNETIC-RESONANCE SPECTROSCOPY OF THE LIVER

被引:0
|
作者
BAUER, H
NEGISHI, C
WEINMANN, HJ
机构
[1] SAITAMA MED SCH,DEPT RADIOL,MOROYAMA,SAITAMA 35004,JAPAN
[2] SCHERING AG,RES LABS,BERLIN,GERMANY
关键词
GADOLINIUM; RAT LIVER; MAGNETIC RESONANCE SPECTROSCOPY; CONTRAST MEDIA; P-31; STUDIES;
D O I
10.1097/00004424-199408000-00004
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
RATIONALE AND OBJECTIVES. The potential of gadolinium compounds (Gd-ethoxybenzyl-DTPA [Gd-EOB-DTPA], gadopentetate dimeglumine [Gd-DTPA], and Gd-chloride [GdCl3]) to enhance the signals from intracellular phosphorus-31 nuclei in the liver was investigated. METHODS. After intravenous administration of Gd-EOB-DTPA, Gd-DTPA, and GdCl3 to rats, liver phosphorus metabolites (inorganic phosphate [Pi], phosphomonoester [PME], and adenosine triphosphate [ATP]) were measured by phosphorus-31 magnetic resonance spectroscopy (MRS). The dose of each compound was 0.2 mmol Gd/kg. Saline was used as a control. RESULTS. The intensities of the phosphorus metabolite signals in the liver showed only minor changes after administration of Gd-DTPA and GdCl3, but increased after Gd-EOB-DTPA. The signals of Pi and PME were enhanced more than those of ATP. The alpha peak of ATP increased by 21.7%, Pi by 61.2%, and PME by 49.2%. CONCLUSIONS. The signal intensities of the phosphorus metabolites in the liver were not influenced by GdCl3. Using Gd-DTPA, only a slight enhancement could be detected. The greatest enhancement was observed with Gd-EOB-DTPA, which has access to the phosphorus metabolites within the hepatocytes. The injection of Gd-EOB-DTPA results in better detectability of the Pi signal.
引用
收藏
页码:752 / 757
页数:6
相关论文
共 50 条
  • [1] INVIVO MONITORING OF FRUCTOSE METABOLISM IN THE HUMAN LIVER BY MEANS OF P-31 MAGNETIC-RESONANCE SPECTROSCOPY
    SEGEBARTH, C
    GRIVEGNEE, AR
    LONGO, R
    LUYTEN, PR
    DENHOLLANDER, JA
    BIOCHIMIE, 1991, 73 (01) : 105 - 108
  • [2] REGIONAL P-31 MAGNETIC-RESONANCE SPECTROSCOPY OF EXERCISING HUMAN MASSETER MUSCLE
    LAM, EWN
    HANNAM, AG
    ARCHIVES OF ORAL BIOLOGY, 1992, 37 (01) : 49 - 56
  • [3] P-31 MAGNETIC-RESONANCE SPECTROSCOPY INVESTIGATION OF SKELETAL-MUSCLE METABOLISM IN UREMIC PATIENTS
    TABORSKY, P
    SOTORNIK, I
    KASLIKOVA, J
    SCHUCK, O
    HAJEK, M
    HORSKA, A
    NEPHRON, 1993, 65 (02) : 222 - 226
  • [4] IMAGE GUIDED LOCALIZED P-31 MAGNETIC-RESONANCE SPECTROSCOPY OF ACUTE URINARY-TRACT OBSTRUCTION
    PARIVAR, F
    BARKER, PB
    NARASIMHAN, PT
    JONES, LW
    ROSS, BD
    JOURNAL OF UROLOGY, 1991, 145 (03) : 657 - 662
  • [5] P-31 MAGNETIC-RESONANCE SPECTROSCOPY OF PERIFUSED HUMAN PLACENTAL VILLI UNDER VARYING OXYGEN CONCENTRATIONS
    KAY, HH
    HAWKINS, SR
    WANG, YP
    MIKA, DE
    RIBEIRO, AA
    SPICER, LD
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 168 (01) : 246 - 252
  • [6] BRAIN PHOSPHORUS-METABOLISM IN DEPRESSIVE-DISORDERS DETECTED BY P-31 MAGNETIC-RESONANCE SPECTROSCOPY
    KATO, T
    TAKAHASHI, S
    SHIOIRI, T
    INUBUSHI, T
    JOURNAL OF AFFECTIVE DISORDERS, 1992, 26 (04) : 223 - 230
  • [7] 31P Magnetic-Resonance Spectroscopy in Cardiac Diseases
    Mazaev, V. V.
    Stukalova, O. V.
    Ternovoy, S. K.
    Chazova, I. E.
    KARDIOLOGIYA, 2012, 52 (03) : 67 - 73
  • [8] MAGNETIC-RESONANCE-IMAGING OF IMPLANTED MELANOMAS BEFORE AND AFTER CHEMOTHERAPY - RELATION TO P-31 MAGNETIC-RESONANCE SPECTROSCOPY AND TUMOR HISTOLOGY
    IYER, SB
    GOLDBERG, HI
    BENZ, CC
    INVESTIGATIVE RADIOLOGY, 1990, 25 (10) : 1076 - 1084
  • [9] Quantitative in vivo P-31 magnetic resonance spectroscopy of Alzheimer disease
    Gonzalez, RG
    Guimaraes, AR
    Moore, GJ
    Crawley, A
    Cupples, LA
    Growdon, JH
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1996, 10 (01) : 46 - 52
  • [10] CARDIOVASCULAR APPLICATIONS OF MAGNETIC-RESONANCE-IMAGING AND P-31 SPECTROSCOPY
    DEROOS, A
    DOORNBOS, J
    REBERGEN, S
    VANRUGGE, P
    PATTYNAMA, P
    VANDERWALL, EE
    EUROPEAN JOURNAL OF RADIOLOGY, 1992, 14 (02) : 97 - 103